DOCMZ Stock Overview
Operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
DocMorris AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF 29.42 |
| 52 Week High | CHF 101.60 |
| 52 Week Low | CHF 28.66 |
| Beta | 1.4 |
| 11 Month Change | -17.91% |
| 3 Month Change | -25.41% |
| 1 Year Change | -45.16% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -80.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| DOCMZ | GB Consumer Retailing | GB Market | |
|---|---|---|---|
| 7D | -12.5% | 2.1% | 2.2% |
| 1Y | -45.2% | 13.5% | 8.0% |
Return vs Industry: DOCMZ underperformed the UK Consumer Retailing industry which returned 13.5% over the past year.
Return vs Market: DOCMZ underperformed the UK Market which returned 8% over the past year.
Price Volatility
| DOCMZ volatility | |
|---|---|
| DOCMZ Average Weekly Movement | 8.8% |
| Consumer Retailing Industry Average Movement | 3.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DOCMZ's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: DOCMZ's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 1,453 | Walter Hess | corporate.docmorris.com/en |
DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritional supplements, painkillers, and first aid products. It also provides professional health care services.
DocMorris AG Fundamentals Summary
| DOCMZ fundamental statistics | |
|---|---|
| Market cap | CHF 380.97m |
| Earnings (TTM) | -CHF 97.26m |
| Revenue (TTM) | CHF 1.00b |
0.4x
P/S Ratio-3.9x
P/E RatioIs DOCMZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCMZ income statement (TTM) | |
|---|---|
| Revenue | CHF 1.00b |
| Cost of Revenue | CHF 792.13m |
| Gross Profit | CHF 210.66m |
| Other Expenses | CHF 307.92m |
| Earnings | -CHF 97.26m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Mar 13, 2025
| Earnings per share (EPS) | -7.54 |
| Gross Margin | 21.01% |
| Net Profit Margin | -9.70% |
| Debt/Equity Ratio | 93.8% |
How did DOCMZ perform over the long term?
See historical performance and comparison